Article: Drug-Covered Balloons Can Match Stents
Article: Drug-Covered Balloons Can Match Stents
Source: Medscape Medical News
Date: October 23, 2026
* DCB vs DES in de novo coronary lesions: similar CV death, MI, thrombosis, and overall revascularization.
* Evidence strongest in small/simple vessels; DES remains preferred for many large/complex lesions.
* DCB advantage: no permanent metal implant (“leave nothing behind”).
* DAPT after DCB: ~1 month in stable CAD; 12 months in ACS (1–3 months if high bleeding risk).
* Bottom line: DCB is a credible alternative to DES in selected de novo lesions.